Hudson Therapeutics And Shaperon Pursue Global Licensing Partnerships
07 Oct 2024 //
BUSINESSWIRE
Hudson And Shaperon Seek Global Licensing At Q4 Conferences
06 Oct 2024 //
BUSINESSWIRE
Hudson Therapeutics Enters Alopecia Areata Market
26 Sep 2024 //
BUSINESSWIRE
Hudson Appoints Janice Marie McCourt as co-Chief Executive Officer
03 Nov 2023 //
BUSINESSWIRE